2-[(2,6-dichlorophenyl)amino]benzeneacetic acid 5-(nitrooxy)ethyloxyethyl ester

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 2-[(2,6-dichlorophenyl)amino]benzeneacetic acid 5-(nitrooxy)ethyloxyethyl ester
• 英文别名: 2-[2-(nitrooxy)ethoxy]ethyl {2-[(2,6-dichlorophenyl)amino]phenyl} acetate；2-(2-Nitrooxyethoxy)ethyl 2-[2-(2,6-dichloroanilino)phenyl]acetate
• 化学式: C₁₈H₁₈Cl₂N₂O₆
• 分子量: 429.257
• InChiKey: SYQXAKPJCDYTQH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  28
• 可旋转键数：
  11
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  103
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  2-{2-[(methylsulfonyl)oxy]ethoxy}ethyl {2-[(2,6-dichlorophenyl)amino]phenyl} acetate 在 sodium nitrate 、 四丁基硝酸铵 作用下， 以 乙酸丁酯 、 乙腈 为溶剂， 反应 50.0h， 以93.4%的产率得到2-[(2,6-dichlorophenyl)amino]benzeneacetic acid 5-(nitrooxy)ethyloxyethyl ester
  参考文献：
  名称：

  [EN] MANUFACTURING PROCESS FOR NO-DONATING COMPOUNDS SUCH AS NO-DONATING DICLOFENAC
  [FR] PROCEDE DE FABRICATION DE COMPOSES DONNEURS DE NO TELS QUE DU DICLOFENAC DONNEUR DE NO

  摘要：

  本发明涉及一种利用磺化中间体制备NO供体化合物的新工艺。该发明涉及其中制备的新中间体，适用于大规模制造NO供体化合物。该发明还涉及利用新中间体制造药用活性NO供体化合物。该发明还涉及NO供体NSAIDs的实质晶体形式，特别是2-[2-(硝基氧基)乙氧基]乙基{2-[(2,6-二氯苯基)氨基]苯基}醋酸酯，其制备以及含有所述晶体形式的药物配方，以及利用所述晶体形式制备药物的用途。

  公开号：

  WO2004026808A1

文献信息

• Manufacturing process for no-donating compounds such as no-donating diclofenac
  申请人：Andersson Johan

  公开号：US20060122402A1

  公开（公告）日：2006-06-08

  The present invention relates to a new process for the preparation of NO-donating compounds using a sulfonated intermediate. The invention relates to new intermediates prepared therein suitable for large scale manufacturing of NO-donating compounds. The invention further relates to the use of the new intermediates for the manufacturing of pharmaceutically active NO-donating compounds. The invention further relates to a substantially crystalline form of NO-donating NSAIDs, especially 2-[2-(nitrooxy)ethoxy]ethyl 2-[(2,6-dichlorophenyl)amino]phenyl}acetate, the preparation thereof and to pharmaceutical formulations containing said crystalline form and to the use of said crystalline form in the preparation of a medicament.

  本发明涉及一种利用磺化中间体制备 NO-捐献化合物的新工艺。本发明涉及由其制备的适用于大规模生产 NO-onating 化合物的新中间体。本发明还涉及利用新中间体制造具有药用活性的 NO-捐献化合物。本发明进一步涉及一种基本结晶形式的NO-供体非甾体抗炎药，特别是2-[2-(硝基氧基)乙氧基]乙基2-[(2,6-二氯苯基)氨基]苯基}乙酸酯，其制备方法和含有所述结晶形式的药物制剂，以及所述结晶形式在制备药物中的用途。
• Drugs for the arthritis treatment
  申请人：Del Soldato Piero

  公开号：US20070010458A1

  公开（公告）日：2007-01-11

  Antiinflammatory and/or antiinflammatory/analgesic compounds having the following general formula: A-(B) b0 —(C) c0 —N(O) s (I) or salts thereof, wherein: A contains the radical of a non steroidal antiinflammatory or non steroidal antiinflammatory/analgesic drug, B and C are bivalent linking groups, are used in the arthritis therapy.
• PHARMACEUTICAL FORMULATION OF NITROOXYDERIVATIVES OF NSAIDS
  申请人：Gasslander Ulla

  公开号：US20090203759A1

  公开（公告）日：2009-08-13

  The present invention relates to a pharmaceutical formulation comprising: a) one or more NO-releasing NSAID(s) of formula (I); b) one or more surfactants; c) a carbonyl scavenger compound selected from free acid forms, salts, carboxylic acid esters derivatives of a compound of formula (II) H 2 N—(CH 2 ) m —(C 6 H 4 )—COOH  (II) wherein m=0-10; and d) optionally an oil or semi-solid fat and/or a short-chain alcohol.
• US8691869B2
  申请人：——

  公开号：US8691869B2

  公开（公告）日：2014-04-08
• [EN] MANUFACTURING PROCESS FOR NO-DONATING COMPOUNDS SUCH AS NO-DONATING DICLOFENAC<br/>[FR] PROCEDE DE FABRICATION DE COMPOSES DONNEURS DE NO TELS QUE DU DICLOFENAC DONNEUR DE NO
  申请人：ASTRAZENECA UK LTD

  公开号：WO2004026808A1

  公开（公告）日：2004-04-01

  The present invention relates to a new process for the preparation of NO-donating compounds using a sulfonated intermediate. The invention relates to new intermediates prepared therein suitable for large scale manufacturing of NO-donating compounds. The invention further relates to the use of the new intermediates for the manufacturing of pharmaceutically active NO-donating compounds.The invention further relates to a substantially crystalline form of NO-donating NSAIDs, especially 2-[2-(nitrooxy)ethoxy]ethyl 2-[(2,6-dichlorophenyl)amino]phenyl}acetate, the preparation thereof and to pharmaceutical formulations containing said crystalline form and to the use of said crystalline form in the preparation of a medicament.

  本发明涉及一种利用磺化中间体制备NO供体化合物的新工艺。该发明涉及其中制备的新中间体，适用于大规模制造NO供体化合物。该发明还涉及利用新中间体制造药用活性NO供体化合物。该发明还涉及NO供体NSAIDs的实质晶体形式，特别是2-[2-(硝基氧基)乙氧基]乙基2-[(2,6-二氯苯基)氨基]苯基}醋酸酯，其制备以及含有所述晶体形式的药物配方，以及利用所述晶体形式制备药物的用途。